<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Le Vasseur M</submitter><funding>Howard Hughes Medical Institute</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>National Institutes of Health</funding><funding>National Institute of General Medical Sciences</funding><funding>National Human Genome Research Institute</funding><pagination>e67624</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8154037</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10</volume><pubmed_abstract>Dysfunction of the mitochondrial electron transport chain (mETC) is a major cause of human mitochondrial diseases. To identify determinants of mETC function, we screened a genome-wide human CRISPRi library under oxidative metabolic conditions with selective inhibition of mitochondrial Complex III and identified ovarian carcinoma immunoreactive antigen (OCIA) domain-containing protein 1 (OCIAD1) as a Complex III assembly factor. We find that OCIAD1 is an inner mitochondrial membrane protein that forms a complex with supramolecular prohibitin assemblies. Our data indicate that OCIAD1 is required for maintenance of normal steady-state levels of Complex III and the proteolytic processing of the catalytic subunit cytochrome c1 (CYC1). In OCIAD1 depleted mitochondria, unprocessed CYC1 is hemylat</pubmed_abstract><journal>eLife</journal><pubmed_title>Genome-wide CRISPRi screening identifies OCIAD1 as a prohibitin client and regulatory determinant of mitochondrial Complex III assembly in human cells.</pubmed_title><pmcid>PMC8154037</pmcid><funding_grant_id>K99HL133372</funding_grant_id><funding_grant_id>R01GM126081</funding_grant_id><funding_grant_id>K99GM130964</funding_grant_id><funding_grant_id>S100D018223</funding_grant_id><funding_grant_id>HHMI</funding_grant_id><funding_grant_id>R00HL133372</funding_grant_id><funding_grant_id>1RM1HG009490</funding_grant_id><funding_grant_id>R37GM097432</funding_grant_id><pubmed_authors>Le Vasseur M</pubmed_authors><pubmed_authors>Yamada J</pubmed_authors><pubmed_authors>Friedman J</pubmed_authors><pubmed_authors>Phinney BS</pubmed_authors><pubmed_authors>Nunnari J</pubmed_authors><pubmed_authors>Jost M</pubmed_authors><pubmed_authors>Horlbeck MA</pubmed_authors><pubmed_authors>Weissman JS</pubmed_authors><pubmed_authors>Kampmann M</pubmed_authors><pubmed_authors>Xu J</pubmed_authors><pubmed_authors>Salemi MR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genome-wide CRISPRi screening identifies OCIAD1 as a prohibitin client and regulatory determinant of mitochondrial Complex III assembly in human cells.</name><description>Dysfunction of the mitochondrial electron transport chain (mETC) is a major cause of human mitochondrial diseases. To identify determinants of mETC function, we screened a genome-wide human CRISPRi library under oxidative metabolic conditions with selective inhibition of mitochondrial Complex III and identified ovarian carcinoma immunoreactive antigen (OCIA) domain-containing protein 1 (OCIAD1) as a Complex III assembly factor. We find that OCIAD1 is an inner mitochondrial membrane protein that forms a complex with supramolecular prohibitin assemblies. Our data indicate that OCIAD1 is required for maintenance of normal steady-state levels of Complex III and the proteolytic processing of the catalytic subunit cytochrome c1 (CYC1). In OCIAD1 depleted mitochondria, unprocessed CYC1 is hemylat</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 May</publication><modification>2025-04-04T10:18:17.876Z</modification><creation>2025-04-04T10:18:17.876Z</creation></dates><accession>S-EPMC8154037</accession><cross_references><pubmed>34034859</pubmed><doi>10.7554/eLife.67624</doi></cross_references></HashMap>